Part II: To CL Or Not To CL: That Ought Not Be The Question
Continuing from Part I, Rishabh Upadhyay explains that making a patented medicine free on paper does not necessarily make it accessible in practice. Through Rajasthan’s procurement and distribution model for Ribociclib, he argues that India’s access-to-medicines challenge is ultimately an infrastructural one, not merely a patent-law problem. Rishabh is an LL.M. candidate at South Asian University, having completed his undergraduate legal studies at the Faculty of Law, Banaras Hindu University. His interest lies in intellectual property jurisprudence, with particular emphasis […]
Part II: To CL Or Not To CL: That Ought Not Be The Question Read More »









